Global Paxlovid API Market Size study & Forecast, by Type (Purity 99%~, Purity 99.5%~), by Application (COVID-19 Oral Drugs, Research Reagents, Other) and Regional Analysis, 2023-2030

Description

List of Tables

Global Paxlovid API Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Paxlovid is a medicine that combines two antiviral drugs. It is authorized for the treatment of mild to moderate COVID-19 illnesses. The increasing demand for Paxlovid API in the pharmaceutical industry is the key factor responsible for market growth over the forecast period of 2023-2030.

The primary key factor anticipated to accelerate the growth of the Paxlovid API Market is the increasing demand in the pharmaceutical industry for the treatment of Covid illness. For instance- according to the World Health Organization, In Apr 2020, SARS-CoV-2 spread to over 209 countries and territories, with over 2,314,621 confirmed coronavirus cases recorded and 157,847 deaths globally. Also, increasing funding by the government for research and development for medications for COVID-19 and growing healthcare expenditure are creating a lucrative growth prospectus for the market over the forecast period. Moreover, the growing aging population and technological advancements create a positive outlook for the market. However, side effects of Paxlovid stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Paxlovid API Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue owing to factors such as growing investments by the government in research & development in the biomedical and pharmaceuticals industry. Asia-Pacific is the fastest-growing region due to technology replacement and continuous innovations.

Major market player included in this report are:

Pfizer Inc
Merck & Co. Inc.
Ridgeback Biotherapeutics LP
Cipla Limited
Hetero Labs Limited
Sun Pharmaceutical Industries Ltd.
Laurus Labs Limited
Dr. Reddy's Laboratories Ltd.
Mylan N.V.
Torrent Pharmaceuticals Ltd.

Recent Developments in the Market:

In June 2022, Pfizer has invested $120 million to produce oral treatment for COVID-19, Paxlovid, with the expansion creating more than 250 high-skilled manufacturing jobs at the company's site in Michigan.

Global Paxlovid API Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Type, Application, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

Purity ≥99%
Purity ≥99.5%

By Application:

COVID-19 Oral Drugs
Research Reagents
Other

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Paxlovid API Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Paxlovid API Market, by Type, 2020-2030 (USD Billion)
- 1.2.3. Paxlovid API Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Paxlovid API Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Paxlovid API Market Dynamics

3.1. Paxlovid API Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing demand in pharmaceutical industry
  - 3.1.1.2. Increasing funding by the government for research
- 3.1.2. Market Challenges
  - 3.1.2.1. Side effects of Paxlovid
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing aging population
  - 3.1.3.2. Growing technological advancement in healthcare

Chapter 4. Global Paxlovid API Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Paxlovid API Market, by Type

5.1. Market Snapshot
5.2. Global Paxlovid API Market by Type, Performance - Potential Analysis
5.3. Global Paxlovid API Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Paxlovid API Market, Sub Segment Analysis
- 5.4.1. Purity ≥99%
- 5.4.2. Purity ≥99.5%

Chapter 6. Global Paxlovid API Market, by Application

6.1. Market Snapshot
6.2. Global Paxlovid API Market by Application, Performance - Potential Analysis
6.3. Global Paxlovid API Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Paxlovid API Market, Sub Segment Analysis
- 6.4.1. COVID-19 Oral Drugs
- 6.4.2. Research Reagents
- 6.4.3. Other

Chapter 7. Global Paxlovid API Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Paxlovid API Market by Distribution Channel, Performance - Potential Analysis

Chapter 8. Global Paxlovid API Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Paxlovid API Market, Regional Market Snapshot
8.4. North America Paxlovid API Market
- 8.4.1. U.S. Paxlovid API Market
  - 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Paxlovid API Market
8.5. Europe Paxlovid API Market Snapshot
- 8.5.1. U.K. Paxlovid API Market
- 8.5.2. Germany Paxlovid API Market
- 8.5.3. France Paxlovid API Market
- 8.5.4. Spain Paxlovid API Market
- 8.5.5. Italy Paxlovid API Market
- 8.5.6. Rest of Europe Paxlovid API Market
8.6. Asia-Pacific Paxlovid API Market Snapshot
- 8.6.1. China Paxlovid API Market
- 8.6.2. India Paxlovid API Market
- 8.6.3. Japan Paxlovid API Market
- 8.6.4. Australia Paxlovid API Market
- 8.6.5. South Korea Paxlovid API Market
- 8.6.6. Rest of Asia Pacific Paxlovid API Market
8.7. Latin America Paxlovid API Market Snapshot
- 8.7.1. Brazil Paxlovid API Market
- 8.7.2. Mexico Paxlovid API Market
8.8. Middle East & Africa Paxlovid API Market
- 8.8.1. Saudi Arabia Paxlovid API Market
- 8.8.2. South Africa Paxlovid API Market
- 8.8.3. Rest of Middle East & Africa Paxlovid API Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Pfizer Inc
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Development
- 9.3.2. Merck & Co. Inc.
- 9.3.3. Ridgeback Biotherapeutics LP
- 9.3.4. Cipla Limited
- 9.3.5. Hetero Labs Limited
- 9.3.6. Sun Pharmaceutical Industries Ltd.
- 9.3.7. Laurus Labs Limited
- 9.3.8. Dr. Reddy's Laboratories Ltd.
- 9.3.9. Mylan N.V.
- 9.3.10. Torrent Pharmaceuticals Ltd.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Paxlovid API Market, report scope
TABLE 2. Global Paxlovid API Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Paxlovid API Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Paxlovid API Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Paxlovid API Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Paxlovid API Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Paxlovid API Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Paxlovid API Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Paxlovid API Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Paxlovid API Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Paxlovid API Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Paxlovid API Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Paxlovid API Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Paxlovid API Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Paxlovid API Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Paxlovid API Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Paxlovid API Market
TABLE 70. List of primary sources, used in the study of global Paxlovid API Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Paxlovid API Market, research methodology
FIG 2. Global Paxlovid API Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Paxlovid API Market, key trends 2022
FIG 5. Global Paxlovid API Market, growth prospects 2023-2030
FIG 6. Global Paxlovid API Market, porters 5 force model
FIG 7. Global Paxlovid API Market, pest analysis
FIG 8. Global Paxlovid API Market, value chain analysis
FIG 9. Global Paxlovid API Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Paxlovid API Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Paxlovid API Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Paxlovid API Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Paxlovid API Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Paxlovid API Market, regional snapshot 2020 & 2030
FIG 15. North America Paxlovid API Market 2020 & 2030 (USD Billion)
FIG 16. Europe Paxlovid API Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Paxlovid API Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Paxlovid API Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Paxlovid API Market 2020 & 2030 (USD Billion)